Previous Close | 75.17 |
Open | 75.65 |
Bid | 66.73 x 900 |
Ask | 74.00 x 900 |
Day's Range | 75.08 - 76.58 |
52 Week Range | 67.01 - 103.95 |
Volume | |
Avg. Volume | 71,208 |
Market Cap | 1.481B |
Beta (5Y Monthly) | 0.87 |
PE Ratio (TTM) | 11.62 |
EPS (TTM) | 6.55 |
Earnings Date | Apr 25, 2022 - Apr 29, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 91.50 |
View more earnings on USNASee more from BenzingaVirgin Galactic Shares Surge On Partnership With Boeing's Subsidiary To Build New MothershipsBabylon Shares Gain On Plans To Accelerate Path To ProfitabilityDon't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Usana Health Sciences Inc. shares fell in the extended session Wednesday after the nutritional supplement sales company lowered its forecast for the year, blaming lockdowns in China for disrupting regional sales programs.
SALT LAKE CITY, July 06, 2022--USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary results for the second quarter ended July 2, 2022, and provided an updated outlook for fiscal year 2022. The Company anticipates that second quarter 2022 net sales will be approximately $265 million, which compares with $337 million in the prior-year period. Earnings per share for the quarter are expected to be approximately $1.05, which compares with $1.87 during the second quarter of 2021.